Skip to main content
. 2018 Mar 15;102(5):575–585. doi: 10.1136/bjophthalmol-2017-311258

Table 3.

Age-standardised prevalence of blindness and MSVI and VI by sex and region comparing adults 50 years and older with all ages, for 2015 in high-income countries and in Eastern and Central Europe; 80% uncertainty intervals are given in brackets

Age (years) 50+ All ages
Sex Men Women Men Women
Region Blind MSVI Mild VI Blind MSVI Mild VI Blind MSVI Mild VI Blind MSVI Mild VI
Asia Pacific, high income 0.42 (0.22–0.66) 4.09 (2.08–6.52) 4.15 (1.47–7.51) 0.48 (0.25–0.76) 4.88 (2.48–7.74) 4.83 (1.75–8.64) 0.10 (0.05–0.16) 1.06 (0.53–1.70) 1.09 (0.37–1.99) 0.12 (0.06–0.18) 1.26 (0.63–2.01) 1.26 (0.44–2.28)
Australasia 0.49 (0.20–0.87) 4.79 (2.08–8.28) 4.75 (1.52–9.00) 0.54 (0.22–0.97) 5.42 (2.38–9.27) 5.28 (1.71–9.88) 0.12 (0.05–0.21) 1.25 (0.54–2.17) 1.26 (0.39–2.41) 0.13 (0.05–0.24) 1.41 (0.61–2.43) 1.40 (0.44–2.66)
Europe, Central 0.93 (0.25–1.85) 5.06 (1.59–9.46) 4.77 (1.20–9.58) 0.98 (0.26–2.04) 5.29 (1.58–10.02) 4.94 (1.22–9.92) 0.23 (0.06–0.45) 1.33 (0.41–2.49) 1.29 (0.31–2.59) 0.24 (0.06–0.49) 1.38 (0.40–2.61) 1.32 (0.31–2.66)
Europe, Eastern 0.96 (0.31–1.81) 7.01 (2.73–12.27) 6.44 (1.97–12.25) 0.98 (0.30–1.87) 7.17 (2.72–13.00) 6.53 (2.00–12.36) 0.23 (0.07–0.44) 1.84 (0.70–3.25) 1.75 (0.51–3.38) 0.24 (0.07–0.45) 1.88 (0.69–3.43) 1.76 (0.51–3.39)
Europe, Western 0.42 (0.22–0.67) 3.78 (1.86–6.21) 3.86 (1.31–7.36) 0.48 (0.25–0.76) 4.37 (2.15–7.14) 4.39 (1.52–8.30) 0.10 (0.05–0.16) 0.98 (0.48–1.62) 1.01 (0.33–1.95) 0.12 (0.06–0.18) 1.13 (0.55–1.86) 1.15 (0.39–2.20)
North America, high income 0.56 (0.24–0.98) 4.40 (1.87–7.38) 4.37 (1.43–8.42) 0.63 (0.27–1.09) 5.00 (2.17–8.39) 4.90 (1.63–9.34) 0.14 (0.06–0.24) 1.16 (0.48–1.95) 1.17 (0.37–2.27) 0.15 (0.06–0.27) 1.31 (0.56–2.21) 1.31 (0.42–2.53)
World 1.82 (0.67–3.28) 10.12 (4.85–16.45) 8.33 (3.10–15.02) 1.91 (0.68–3.49) 10.79 (5.00–17.74) 8.77 (3.23–15.84) 0.46 (0.17–0.84) 2.79 (1.29–4.61) 2.46 (0.84–4.55) 0.49 (0.17–0.90) 2.99 (1.33–4.99) 2.60 (0.88–4.85)

MSVI, moderate and severe vision impairment; VI, vision impairment.